Chon, H. J., Hong, J. Y., Bai, X., Zhang, T., Gane, E., Guo, Y., Zheng, T., Wu, J., Huang, Y., Subbiah, V., Abou-Alfa, G. K., Mu, X., Zhu, Z., Zhou, J., Giovinazzo, H., Huang, R., Liang, T. (2026). A phase 1 study of BGB-B2033 (GPC3 x 4-1BB bispecific antibody) monotherapy in patients with selected advanced or metastatic solid tumors: First disclosure of clinical data.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.3016